ChiroBlock GmbH

7. November 2017

ChiroBlock regards itself as dedicated chemical “open innovation” partner. Since its foundation in 1999, the company has been bridging the gap between chemistry related basic research and the demand for new processes and compounds at manufacturers in the “matter based” industries:
“MoleculeFactory”: One-time synthesis of entirely new substances,
“ReDesignFactory”: Development and optimisation of synthetic routes,
“IP-Factory”: Generating own IP,
“SupplyChainFactory”: Qm – regulated syntheses.